(October 26, 2016, 12:41 PM EDT) -- WILMINGTON, Del. — An application by Mylan Pharmaceuticals Inc. to market a generic version of the brand-name drug Colcrys would infringe 17 patents, according to a lawsuit filed Oct. 24 in...
Takeda Takes Aim At Proposed Generic Drug In New Delaware Patent Case
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login